The "Symposium on scientific selection of biological agents and rare diseases" hosted by Chengdu high tech Medical Association was successfully held online on May 13, 2025. This symposium focuses on the field of skin immune diseases, aiming to improve the level of accurate diagnosis and treatment of psoriasis, urticaria and other related diseases, and promote the rational and safe application of biological agents. The

The treatment of skin immune diseases has always been the key field of immunology translational medicine. In the past, such diseases mainly relied on drugs or therapies discovered by chance, with limited efficacy and toxicity risk in long-term use. With the advent of biological agents, many patients have achieved significant improvement in skin lesions and itching symptoms. However, there are still many problems to be solved in the pharmaceutical mechanism, rational use and long-term management of biological agents. The

In view of these clinical pain points, this symposium invited a number of industry experts to conduct in-depth discussions, covering the scientific selection of biological agents, the progress of diagnosis and treatment of rare diseases and other aspects, providing a platform for participants to exchange and learn, which is of great significance to promote the standardized treatment of skin immune diseases and long-term management of patients.